BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Oncology News, Insights, Stories by OncoDaily - ECPv6.16.2//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Oncology News, Insights, Stories by OncoDaily
X-ORIGINAL-URL:https://oncodailynews.com
X-WR-CALDESC:Events for Oncology News, Insights, Stories by OncoDaily
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/Halifax
BEGIN:DAYLIGHT
TZOFFSETFROM:-0400
TZOFFSETTO:-0300
TZNAME:ADT
DTSTART:20250309T060000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0300
TZOFFSETTO:-0400
TZNAME:AST
DTSTART:20251102T050000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0400
TZOFFSETTO:-0300
TZNAME:ADT
DTSTART:20260308T060000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0300
TZOFFSETTO:-0400
TZNAME:AST
DTSTART:20261101T050000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0400
TZOFFSETTO:-0300
TZNAME:ADT
DTSTART:20270314T060000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0300
TZOFFSETTO:-0400
TZNAME:AST
DTSTART:20271107T050000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0400
TZOFFSETTO:-0300
TZNAME:ADT
DTSTART:20280312T060000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0300
TZOFFSETTO:-0400
TZNAME:AST
DTSTART:20281105T050000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:Europe/Madrid
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20250330T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20251026T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20260329T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20261025T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20270328T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20271031T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20280326T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20281029T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20290325T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20291028T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260803
DTEND;VALUE=DATE:20261013
DTSTAMP:20260911T174144
CREATED:20260720T142239Z
LAST-MODIFIED:20260720T142608Z
UID:10000802-1785715200-1791849599@oncodailynews.com
SUMMARY:ESMO Academy 2026
DESCRIPTION:The ESMO Academy 2026\, organized by the European Society for Medical Oncology (ESMO)\, will take place virtually from 3 August to 12 October 2026. \nThe programme will combine on-demand educational modules with live interactive sessions led by ESMO faculty\, covering major tumour types\, clinical trial methodology\, treatment principles\, pharmacokinetics\, drug interactions\, and topics relevant to the ESMO Examination. Access is initially limited to participants registered for the ESMO Examination 2026\, while the modules will become available to all ESMO members from November 2026. Registered participants will receive access details closer to the course start date.
URL:https://oncodailynews.com/event/esmo-academy-2026-546719
ATTACH;FMTTYPE=image/webp:https://oncodailynews.com/pub/uploads/2026/07/ChatGPT-Image-Jul-20-2026-06_21_08-PM.webp
ORGANIZER;CN="European Society For Medical Oncology (ESMO)":MAILTO:esmo@esmo.org
LOCATION:
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260910
DTEND;VALUE=DATE:20260912
DTSTAMP:20260911T174144
CREATED:20251126T131341Z
LAST-MODIFIED:20251126T131416Z
UID:10000410-1788998400-1789171199@oncodailynews.com
SUMMARY:Molecular Analysis for Precision Oncology Congress 2026
DESCRIPTION:The Molecular Analysis for Precision Oncology (MAP) Congress 2026\, co-organized by the European Society for Medical Oncology (ESMO)\, Cancer Research UK (CRUK)\, and Unicancer\, is scheduled for 10–11 September 2026 in London\, United Kingdom. \nThis high-level\, two-day meeting will serve as a platform for experts in oncology\, molecular diagnostics\, and precision medicine to converge and exchange ideas. \nThe primary focus of the congress is to share advances in cancer research\, strengthen interdisciplinary connections\, and accelerate the translation of molecular insights – particularly concerning molecular profiling\, biomarker discovery\, and personalized treatment strategies – into routine clinical practice to improve global patient care.
URL:https://oncodailynews.com/event/precision-oncology-416782
LOCATION:London\, United Kingdom
ATTACH;FMTTYPE=image/webp:https://oncodailynews.com/pub/uploads/2025/11/MAP2026.webp
ORGANIZER;CN="European Society For Medical Oncology (ESMO)":MAILTO:esmo@esmo.org
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260918
DTEND;VALUE=DATE:20260920
DTSTAMP:20260911T174144
CREATED:20260126T222113Z
LAST-MODIFIED:20260126T222126Z
UID:10000627-1789689600-1789862399@oncodailynews.com
SUMMARY:ESMO Preceptorship on Tumour-agnostic and Cancer of Unknown Primary 2026: Zurich
DESCRIPTION:The ESMO Preceptorship on Tumour-agnostic and Cancer of Unknown Primary 2026 is scheduled to take place in Zurich\, Switzerland\, from September 18–19\, 2026. \nChaired by Natalie Cook and Benedikt Westphalen\, this educational course aims to provide oncologists with a comprehensive understanding of the management of these complex diseases\, from diagnosis to treatment\, according to current standards of care. \nThe program focuses on the reshaping of cancer care through tumour-agnostic therapies andprecision oncology\, offering participants the opportunity to learn from leaders in the field while earning 10 ESMO-MORA category 1 points. Applications for the course open with a deadline of June 3\, 2026\, and successful applicants benefit from complimentary registration and accommodation.
URL:https://oncodailynews.com/event/esmo-preceptorship-447566
LOCATION:Zurich\, Switzerland
ATTACH;FMTTYPE=image/webp:https://oncodailynews.com/pub/uploads/2026/01/ESMO-1-1.webp
ORGANIZER;CN="European Society For Medical Oncology (ESMO)":MAILTO:esmo@esmo.org
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260929
DTEND;VALUE=DATE:20261001
DTSTAMP:20260911T174144
CREATED:20260721T145538Z
LAST-MODIFIED:20260721T145557Z
UID:10000809-1790640000-1790812799@oncodailynews.com
SUMMARY:ESMO Preceptorship on Supportive Care Needs and Cachexia Management in Cancer Patients 2026
DESCRIPTION:The ESMO Preceptorship on Supportive Care Needs and Cachexia Management in Cancer Patients 2026\, organized by the European Society for Medical Oncology (ESMO)\, will take place on 29–30 September 2026 in Lugano\, Switzerland. \nThe course will focus on managing cancer-related symptoms\, cachexia\, nutritional needs\, treatment toxicities\, palliative care\, end-of-life preparation\, and communication with patients and families. Applications close on 26 July 2026 at 23:59 CEST. Non-local participants may receive a travel grant of up to €600\, and the programme is accredited with 11 ESMO-MORA Category 1 points. \nApply Now.
URL:https://oncodailynews.com/event/cancer-patients-2026-547812
LOCATION:Lugano\, Switzerland
ATTACH;FMTTYPE=image/webp:https://oncodailynews.com/pub/uploads/2026/07/ChatGPT-Image-Jul-21-2026-06_43_45-PM.webp
ORGANIZER;CN="European Society For Medical Oncology (ESMO)":MAILTO:esmo@esmo.org
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260930
DTEND;VALUE=DATE:20261001
DTSTAMP:20260911T174144
CREATED:20260127T204408Z
LAST-MODIFIED:20260127T204424Z
UID:10000636-1790726400-1790812799@oncodailynews.com
SUMMARY:ESMO Guidelines: Real World Cases - Webinar Series: Uveal Melanoma 2026
DESCRIPTION:The ESMO Guidelines: Real World Cases – Webinar Series: Uveal Melanoma 2026 is scheduled for Wednesday\, September 30\, 2026\, starting at 18:30 CEST. \nAs uveal melanoma remains a rare and biologically distinct entity from cutaneous melanoma\, this webinar provides a critical platform for presenting evidence-based recommendations from the ESMO Clinical Practice Guidelines through the lens of daily practice. \nChaired by Olivier Michielin\, the session features a multidisciplinary expert panel including Jorja Braden\, Sophie Piperno-Neumann\, Erick Saldanha\, and Mauricio Fernando Silva Almeida Ribeiro. The program focuses on translating recent breakthroughs – such as the efficacy of tebentafusp – into practical clinical strategies\, addressing implementation barriers\, and utilizing molecular profiling to optimize patient management. \nRegister.
URL:https://oncodailynews.com/event/esmo-guidelines-448014
ATTACH;FMTTYPE=image/webp:https://oncodailynews.com/pub/uploads/2026/01/ESMO-Guidelines-1.webp
ORGANIZER;CN="European Society For Medical Oncology (ESMO)":MAILTO:esmo@esmo.org
LOCATION:
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Halifax:20260930T183000
DTEND;TZID=America/Halifax:20260930T183000
DTSTAMP:20260911T174144
CREATED:20260826T121211Z
LAST-MODIFIED:20260826T121258Z
UID:10000957-1790793000-1790793000@oncodailynews.com
SUMMARY:ESMO Guidelines: Real World Cases – Early Stage and Locally Advanced NSCLC 2026
DESCRIPTION:The ESMO Guidelines: Real World Cases Webinar – Early Stage and Locally Advanced NSCLC 2026\, organized by the European Society for Medical Oncology (ESMO)\, will take place on September 30\, 2026\, at 6:30 PM CEST (8:30 PM AMT). \nThe webinar will review the latest evidence-based recommendations for early-stage and locally advanced non-small-cell lung cancer (NSCLC)\, with a particular focus on translating the ESMO Clinical Practice Guidelines into everyday clinical decision-making through discussion of a real-world patient case. \nThe expert session is designed to help participants critically assess guideline recommendations\, consider their practical implementation\, and apply current standards of care to multidisciplinary management of patients with potentially curable NSCLC. Participants attending the live webinar can earn 1 ESMO-MORA Category 1 point.
URL:https://oncodailynews.com/event/esmo-guidelines-574931
ATTACH;FMTTYPE=image/webp:https://oncodailynews.com/pub/uploads/2026/08/ChatGPT-Image-Aug-26-2026-04_10_40-PM.webp
ORGANIZER;CN="European Society For Medical Oncology (ESMO)":MAILTO:esmo@esmo.org
LOCATION:
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20261002
DTEND;VALUE=DATE:20261004
DTSTAMP:20260911T174144
CREATED:20260721T160010Z
LAST-MODIFIED:20260721T160010Z
UID:10000811-1790899200-1791071999@oncodailynews.com
SUMMARY:ESMO Advanced Course on Precision Treatment Sequencing in Metastatic Breast Cancer 2026
DESCRIPTION:The ESMO Advanced Course on Precision Treatment Sequencing in Metastatic Breast Cancer 2026\, organized by the European Society for Medical Oncology (ESMO)\, will take place on 2–3 October 2026 in Singapore. \nThe course will focus on treatment sequencing\, the biology of metastatic breast cancer\, targeted therapy safety and adverse-event management\, and multidisciplinary approaches to improving patient outcomes. Applications close on 21 August 2026 at 23:59 CEST. Non-local participants may receive a travel grant of up to €600\, and the programme is accredited with 10 ESMO-MORA Category 1 points. \nApply Now.
URL:https://oncodailynews.com/event/metastatic-breast-cancer-2026-547927
LOCATION:Singapore\, Republic of Singapore
ATTACH;FMTTYPE=image/webp:https://oncodailynews.com/pub/uploads/2026/07/ChatGPT-Image-Jul-21-2026-07_50_11-PM.webp
ORGANIZER;CN="European Society For Medical Oncology (ESMO)":MAILTO:esmo@esmo.org
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20261002
DTEND;VALUE=DATE:20261004
DTSTAMP:20260911T174144
CREATED:20260721T161206Z
LAST-MODIFIED:20260721T161206Z
UID:10000812-1790899200-1791071999@oncodailynews.com
SUMMARY:ESMO Advanced Course on Optimising Treatment Sequencing in Advanced NSCLC
DESCRIPTION:The ESMO Advanced Course on Optimising Treatment Sequencing in Advanced NSCLC 2026\, oorganized by the European Society for Medical Oncology (ESMO)\, will take place on 2–3 October 2026 in Singapore. \nThe course will focus on sequencing strategies for actionable genomic alteration-positive NSCLC\, biomarker-driven treatment using NGS\, immunohistochemistry\, and liquid biopsy\, and emerging therapies such as antibody–drug conjugates\, bispecific antibodies\, cellular therapies\, and vaccines. It will also address multidisciplinary management of oligometastatic disease and brain metastases. Applications close on 10 August 2026 at 23:59 CEST\, and non-local participants may receive a travel grant of up to €600. \nApply Now.
URL:https://oncodailynews.com/event/advanced-nsclc-547940
LOCATION:Singapore\, Republic of Singapore
ATTACH;FMTTYPE=image/webp:https://oncodailynews.com/pub/uploads/2026/07/ChatGPT-Image-Jul-21-2026-08_06_59-PM.webp
ORGANIZER;CN="European Society For Medical Oncology (ESMO)":MAILTO:esmo@esmo.org
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Halifax:20261007T183000
DTEND;TZID=America/Halifax:20261007T183000
DTSTAMP:20260911T174144
CREATED:20260826T122502Z
LAST-MODIFIED:20260826T122502Z
UID:10000958-1791397800-1791397800@oncodailynews.com
SUMMARY:ESMO Deep Dive: The Evolving Landscape in Relapsed Ovarian Cancer 2026
DESCRIPTION:The ESMO Deep Dive: Gynaecological Cancers – The Evolving Landscape in the Treatment of Relapsed Ovarian Cancer 2026\, organized by the European Society for Medical Oncology (ESMO)\, will take place on October 7\, 2026\, at 6:30 PM CEST (8:30 PM AMT). \nThis live educational webinar will examine how new concepts and therapeutic strategies are reshaping the management of relapsed ovarian cancer\, with particular attention to evolving treatment classifications and the growing role of antibody–drug conjugates (ADCs). \nThe expert discussion will address how emerging therapies may be integrated and sequenced within current treatment pathways\, providing practical insights for clinicians managing patients with recurrent disease. Participants attending the live session can earn 2 ESMO-MORA Category 1 points.
URL:https://oncodailynews.com/event/esmo-deep-dive-574943
ATTACH;FMTTYPE=image/webp:https://oncodailynews.com/pub/uploads/2026/08/ChatGPT-Image-Aug-26-2026-04_23_56-PM.webp
ORGANIZER;CN="European Society For Medical Oncology (ESMO)":MAILTO:esmo@esmo.org
LOCATION:
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20261023
DTEND;VALUE=DATE:20280205
DTSTAMP:20260911T174144
CREATED:20250715T190605Z
LAST-MODIFIED:20260127T204055Z
UID:10000218-1792742400-1833296400@oncodailynews.com
SUMMARY:The ESMO Congress 2026
DESCRIPTION:The ESMO Congress 2026 will take place from 23–27 October in Madrid\, Spain\, bringing together oncology professionals from around the world. \nThis global event serves as a key platform for presenting groundbreaking research\, advancing clinical practice\, and shaping patient care in oncology. Attendees can expect new data releases\, interactive educational sessions\, networking opportunities\, and an innovative exhibition area. \nLed by Congress President Fabrice André\, along with Scientific Co-Chairs Yelena Janjigian and James Larkin\, and Educational Chair Nadia Harbeck\, the congress will cover the latest developments across all areas of cancer care. By joining ESMO 2026\, participants contribute to global progress in oncology while staying up to date with the most relevant clinical and research advancements. \nRead More Posts Featuring ESMO at OncoDaily.com.
URL:https://oncodailynews.com/event/esmo-329848
LOCATION:Madrid\, Madrid\, Spain
ATTACH;FMTTYPE=image/jpeg:https://oncodailynews.com/pub/uploads/2025/07/IMG_7216.jpg
ORGANIZER;CN="European Society For Medical Oncology (ESMO)":MAILTO:esmo@esmo.org
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20261111
DTEND;VALUE=DATE:20261113
DTSTAMP:20260911T174144
CREATED:20260127T203943Z
LAST-MODIFIED:20260127T203943Z
UID:10000635-1794355200-1794527999@oncodailynews.com
SUMMARY:ESMO Advanced Course on Brain Metastases in Lung and Breast Cancer 2026: Barcelona
DESCRIPTION:The ESMO Advanced Course on Brain Metastases in Lung and Breast Cancer 2026: Barcelona is scheduled to take place in Barcelona\, Spain\, from November 11–12\, 2026. \nThis specialized educational program is co-chaired by Simon Ekman\, Lizza Hendriks\, and Natasha Leighl\, and focuses on providing oncologists with high-level training on the evolving diagnostic and therapeutic strategies for brain metastases originating from lung and breast malignancies. The course is designed to address the clinical challenges of managing central nervous system involvement\, highlighting the latest research\, systemic therapies\, and multidisciplinary approaches essential for optimizing patient outcomes in these complex cases. \nApplication.
URL:https://oncodailynews.com/event/brain-metastases-448007
LOCATION:Barcelona\, Spain
ATTACH;FMTTYPE=image/webp:https://oncodailynews.com/pub/uploads/2026/01/ESMO-8.webp
ORGANIZER;CN="European Society For Medical Oncology (ESMO)":MAILTO:esmo@esmo.org
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20261113
DTEND;VALUE=DATE:20261115
DTSTAMP:20260911T174144
CREATED:20260826T134459Z
LAST-MODIFIED:20260826T134459Z
UID:10000961-1794528000-1794700799@oncodailynews.com
SUMMARY:The ESMO Advanced Course on Cholangiocarcinoma 2026
DESCRIPTION:The ESMO Advanced Course on Cholangiocarcinoma 2026\, organized by the European Society for Medical Oncology (ESMO)\, will take place on November 13–14\, 2026\, in Barcelona\, Spain. \nThe course is designed to provide an advanced multidisciplinary update on the diagnosis and management of cholangiocarcinoma\, covering diagnostic challenges\, clinical and molecular differences between disease subtypes\, adjuvant and palliative treatment strategies\, surgery and other locoregional therapies\, immunotherapy\, and currently available and emerging targeted treatments for advanced disease. \nThe programme is aimed at oncology professionals seeking deeper practical knowledge of this complex malignancy and has been accredited with 11 ESMO-MORA Category 1 points.
URL:https://oncodailynews.com/event/advanced-course-on-cholangiocarcinoma-574980
LOCATION:Barcelona\, Barcelona\, Catalonia\, Spain
ATTACH;FMTTYPE=image/webp:https://oncodailynews.com/pub/uploads/2026/08/ChatGPT-Image-Aug-26-2026-05_12_07-PM.webp
ORGANIZER;CN="European Society For Medical Oncology (ESMO)":MAILTO:esmo@esmo.org
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20261116
DTEND;VALUE=DATE:20261119
DTSTAMP:20260911T174144
CREATED:20251127T193756Z
LAST-MODIFIED:20251127T193815Z
UID:10000412-1794787200-1795046399@oncodailynews.com
SUMMARY:ESMO AI and Digital Oncology Congress 2026
DESCRIPTION:The ESMO AI and Digital Oncology Congress 2026 will take place from November 16-18\, 2026\, in Berlin\, Germany. \nThis congress is designed as a central meeting point that facilitates the exchange of the latest research\, promotes ethical dialogue\, and highlights technological innovation in cancer care. \nIt brings together healthcare and digital health experts from around the world to foster collaboration\, inspire learning\, and empower oncology professionals to stay ahead in the rapidly evolving digital transformation of medicine. \nThe specific congress venue within Berlin is expected to be announced on the official European Society for Medical Oncology (ESMO) website closer to the event date.
URL:https://oncodailynews.com/event/esmo-417477
LOCATION:Berlin\, Germany
ATTACH;FMTTYPE=image/webp:https://oncodailynews.com/pub/uploads/2025/11/ESMO-2.webp
ORGANIZER;CN="European Society For Medical Oncology (ESMO)":MAILTO:esmo@esmo.org
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20261204
DTEND;VALUE=DATE:20261207
DTSTAMP:20260911T174144
CREATED:20260105T000502Z
LAST-MODIFIED:20260105T000508Z
UID:10000552-1796342400-1796601599@oncodailynews.com
SUMMARY:ESMO Asia Congress 2026
DESCRIPTION:The ESMO Asia Congress 2026 is the premier scientific platform in the Asia-Pacific region for oncology professionals\, scheduled for December 4-6\, 2026\, in Singapore. \nOrganized by the European Society for Medical Oncology (ESMO)\, this major international congress brings together global experts and regional leaders to present the latest research and clinical data across all major tumor types. \nThe technical program features high-level scientific symposia\, educational sessions on state-of-the-art treatments\, and a dedicated Young Oncologists track aimed at fostering the next generation of cancer researchers. The event emphasizes regional specificities in cancer management and promotes collaborative research to improve patient outcomes throughout Asia.
URL:https://oncodailynews.com/event/esmo-asia-436785
LOCATION:Suntec Singapore Convention & Exhibition Centre\, 1 Raffles Boulevard Singapore\, Singapore\, 039593\, Singapore
ATTACH;FMTTYPE=image/webp:https://oncodailynews.com/pub/uploads/2026/01/ESMO-Asia-1.webp
ORGANIZER;CN="European Society For Medical Oncology (ESMO)":MAILTO:esmo@esmo.org
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20261214
DTEND;VALUE=DATE:20261217
DTSTAMP:20260911T174144
CREATED:20251211T193956Z
LAST-MODIFIED:20251211T194040Z
UID:10000476-1797206400-1797465599@oncodailynews.com
SUMMARY:ESMO Immuno-Oncology Congress 2026
DESCRIPTION:The ESMO Immuno-Oncology Congress 2026 is a premier international event hosted by the European Society for Medical Oncology (ESMO)\, scheduled for December 14–16\, 2026\, as an onsite event in London\, United Kingdom\, with an online option also available. \nThe congress serves as a critical platform for exchanging knowledge and fostering collaboration in immuno-oncology\, covering the entire spectrum of the field from basic science to translational research and clinical development. The meeting will feature the latest scientific advances\, offering researchers\, clinicians\, and other stakeholders excellent opportunities to interact\, share expertise\, and engage with the global community committed to advancing cancer care through innovation.
URL:https://oncodailynews.com/event/immuno-oncology-426416
LOCATION:London\, United Kingdom
ATTACH;FMTTYPE=image/webp:https://oncodailynews.com/pub/uploads/2025/12/ESMO-IO-2026.webp
ORGANIZER;CN="European Society For Medical Oncology (ESMO)":MAILTO:esmo@esmo.org
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20270115
DTEND;VALUE=DATE:20270118
DTSTAMP:20260911T174144
CREATED:20260826T143152Z
LAST-MODIFIED:20260826T143152Z
UID:10000963-1799971200-1800230399@oncodailynews.com
SUMMARY:The Inaugural ESMO Genitourinary Cancers Asia 2027
DESCRIPTION:The Inaugural ESMO Genitourinary Cancers Asia 2027\, organized by the European Society for Medical Oncology (ESMO)\, will take place on January 15–17\, 2027\, at the Kerry Hotel Hong Kong in Hong Kong SAR\, China. \nThe new congress is dedicated to advancing genitourinary oncology across the Asia-Pacific region\, bringing together regional and international experts for multidisciplinary discussion and presentation of practice-changing research. \nThe scientific programme will cover prostate\, bladder\, kidney\, testicular\, and other genitourinary cancers\, with a focus on clinically relevant evidence\, regional perspectives\, research collaboration\, and innovation in GU cancer care. Abstract submission is open until October 13\, 2026\, and registration is now open\, with the early registration deadline on November 11\, 2026.
URL:https://oncodailynews.com/event/esmo-genitourinary-cancers-asia-575063
LOCATION:Kerry Hotel Hong Kong\, 38 Hung Luen Road\, Hung Hom Bay\, Kowloon\, Hong Kong\, Kowloon\, China
ATTACH;FMTTYPE=image/webp:https://oncodailynews.com/pub/uploads/2026/08/ChatGPT-Image-Aug-26-2026-06_31_15-PM.webp
ORGANIZER;CN="European Society For Medical Oncology (ESMO)":MAILTO:esmo@esmo.org
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20270308
DTEND;VALUE=DATE:20270311
DTSTAMP:20260911T174144
CREATED:20260822T124507Z
LAST-MODIFIED:20260822T124507Z
UID:10000939-1804464000-1804723199@oncodailynews.com
SUMMARY:The ESMO Novel Cancer Therapies 2027
DESCRIPTION:The ESMO Novel Cancer Therapies 2027\, organized by the European Society for Medical Oncology (ESMO)\, will take place on March 8–10\, 2027\, in Lugano\, Switzerland. \nThis new ESMO meeting is designed for multidisciplinary oncology professionals and will focus on how approved novel cancer therapies can be translated into everyday clinical practice\, with particular attention to treatment selection\, practical implementation\, toxicity prevention and management\, and optimizing patient outcomes. \nThe programme will combine expert presentations\, multidisciplinary discussions\, real-world clinical cases\, and peer-to-peer learning. Day 1 will feature a major focus on antibody-drug conjugates (ADCs)\, including their clinical use\, supportive care considerations\, management of ADC-related toxicities\, and practical issues around combinations and treatment sequencing. \nAccess the online programme.
URL:https://oncodailynews.com/event/esmo-novel-cancer-therapies-572176
LOCATION:Lugano\, Lugano\, Ticino\, Switzerland
ATTACH;FMTTYPE=image/webp:https://oncodailynews.com/pub/uploads/2026/08/esmo-1-1.webp
ORGANIZER;CN="European Society For Medical Oncology (ESMO)":MAILTO:esmo@esmo.org
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20270317
DTEND;VALUE=DATE:20270321
DTSTAMP:20260911T174144
CREATED:20260825T230738Z
LAST-MODIFIED:20260825T230738Z
UID:10000953-1805241600-1805587199@oncodailynews.com
SUMMARY:The European Lung Cancer Congress 2027
DESCRIPTION:The European Lung Cancer Congress 2027 (ELCC 2027) will take place on March 17–20\, 2027\, in Munich\, Germany\, with both onsite and online participation. \nThe congress is jointly organized by the European Society for Medical Oncology (ESMO) and the International Association for the Study of Lung Cancer (IASLC) and brings together the multidisciplinary thoracic oncology community to advance science\, share education\, and improve clinical practice for patients with lung and other thoracic cancers. \nThe programme is designed for medical oncologists\, radiation oncologists\, thoracic surgeons\, respiratory physicians and pneumologists\, interventional radiologists\, pathologists\, and other professionals involved in thoracic cancer care\, with an emphasis on cross-specialty discussion\, emerging evidence\, and practical take-home insights that can inform everyday patient management.
URL:https://oncodailynews.com/event/european-lung-cancer-congress-574706
LOCATION:ICM – International Congress Center Messe München\, Am Messesee 2\, Munich\, Bavaria\, 81829\, Germany
ATTACH;FMTTYPE=image/webp:https://oncodailynews.com/pub/uploads/2026/08/ChatGPT-Image-Aug-26-2026-03_05_49-AM.webp
ORGANIZER;CN="European Society For Medical Oncology (ESMO)":MAILTO:esmo@esmo.org
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20270917
DTEND;VALUE=DATE:20270922
DTSTAMP:20260911T174144
CREATED:20251127T194612Z
LAST-MODIFIED:20251127T194628Z
UID:10000413-1821139200-1821571199@oncodailynews.com
SUMMARY:ESMO Congress 2027
DESCRIPTION:The ESMO Congress 2027 will take place in Barcelona\, Spain\, from September 17–21\, 2027. \nThis event is recognized as a leading global oncology meeting that serves as a platform for progress by showcasing the latest breakthroughs in oncology research\, clinical practice\, and patient care. The congress brings together a diverse community\, including clinicians\, researchers\, patient advocates\, journalists\, and healthcare industry representatives. \nParticipants can anticipate a dynamic program featuring: \n\nImpactful new data from oncology research.\nInteractive educational sessions.\nUnique networking opportunities.\nA dynamic exhibition area.\n\nBy attending\, participants will gain first-hand insights into the most recent advances and contribute to shaping the future of oncology worldwide.
URL:https://oncodailynews.com/event/esmo-congress-2027-417485
LOCATION:Barcelona\, Spain
ATTACH;FMTTYPE=image/webp:https://oncodailynews.com/pub/uploads/2025/11/16_9-1-2.webp
ORGANIZER;CN="European Society For Medical Oncology (ESMO)":MAILTO:esmo@esmo.org
END:VEVENT
END:VCALENDAR